Literature DB >> 23879470

Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer.

Masato Kasuga1, Kohjiro Ueki, Naoko Tajima, Mitsuhiko Noda, Ken Ohashi, Hiroshi Noto, Atsushi Goto, Wataru Ogawa, Ryuichi Sakai, Shoichiro Tsugane, Nobuyuki Hamajima, Hitoshi Nakagama, Kazuo Tajima, Kohei Miyazono, Kohzoh Imai.   

Abstract

In recent years, diabetes has been shown to be associated with cancer risk, and this has led to a joint committee being formed, enlisting experts from the Japan Diabetes Society and the Japanese Cancer Association to address this issue. Epidemiological data in Japan provides evidence to demonstrate that diabetes is associated with increased risk for cancers, especially colorectal, liver, and pancreatic cancers. The mechanisms through which diabetes is assumed to promote oncogenesis include insulin resistance and associated hyperinsulinemia, hyperglycemia, and inflammation. Common risk factors for type 2 diabetes and cancer include aging, male sex, obesity, physical inactivity, inappropriate diet (excessive red/processed meat intake, inadequate vegetable/fruit/dietary fiber intake), excessive alcohol drinking, and smoking. Given that inappropriate diet/exercise, smoking and excessive alcohol drinking are common risk factors for diabetes and cancer, diet/exercise therapy, smoking cessation and alcohol moderation may be associated with decreased risk for cancer in diabetic patients. There is as yet limited evidence as to whether any particular antidiabetic agents may influence cancer risk.
© 2013 The Japanese Cancer Association and the Japan Diabetes Society.

Entities:  

Mesh:

Year:  2013        PMID: 23879470     DOI: 10.1111/cas.12203

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  32 in total

1.  Controversy regarding gastric cancer and diabetes.

Authors:  Midori Fujishiro; Hisamitsu Ishihara
Journal:  J Gastroenterol       Date:  2015-08-29       Impact factor: 7.527

2.  Association between dietary carbohydrate intake, glycemic index and glycemic load, and risk of gastric cancer.

Authors:  Yao Ye; Yihua Wu; Jinming Xu; Kefeng Ding; Xiaoyun Shan; Dajing Xia
Journal:  Eur J Nutr       Date:  2016-02-12       Impact factor: 5.614

3.  Glycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus.

Authors:  Akihiko Okamura; Masayuki Watanabe; Yu Imamura; Masaru Hayami; Kotaro Yamashita; Takanori Kurogochi; Shinji Mine
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

4.  Cohort Profile: The Maule Cohort (MAUCO).

Authors:  Catterina Ferreccio; Andrea Huidobro; Sandra Cortés; Claudia Bambs; Pablo Toro; Vanessa Van De Wyngard; Johanna Acevedo; Fabio Paredes; Pía Venegas; Hugo Verdejo; Ximena Oyarzún-González; Paz Cook; Pablo F Castro; Claudia Foerster; Claudio Vargas; Jill Koshiol; Juan Carlos Araya; Francisco Cruz; Alejandro H Corvalán; Andrew F Quest; Marcelo J Kogan; Sergio Lavandero
Journal:  Int J Epidemiol       Date:  2020-06-01       Impact factor: 7.196

5.  Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.

Authors:  Yasushi Adachi; Masanori Nojima; Mitsuru Mori; Yasutaka Matsunaga; Noriyuki Akutsu; Shigeru Sasaki; Takao Endo; Youichi Kurozawa; Kenji Wakai; Akiko Tamakoshi
Journal:  Tumour Biol       Date:  2016-09-23

6.  Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.

Authors:  Akiko Hanyuda; Sun A Kim; Alejandro Martinez-Fernandez; Zhi Rong Qian; Mai Yamauchi; Reiko Nishihara; Teppei Morikawa; Xiaoyun Liao; Kentaro Inamura; Kosuke Mima; Yin Cao; Xuehong Zhang; Kana Wu; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Ramesh A Shivdasani; Shuji Ogino
Journal:  Ann Surg Oncol       Date:  2015-11-17       Impact factor: 5.344

7.  The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.

Authors:  Misuzu Ueyama; Nao Nishida; Masaaki Korenaga; Keiko Korenaga; Erina Kumagai; Hidekatsu Yanai; Hiroki Adachi; Hisayuki Katsuyama; Sumie Moriyama; Hidetaka Hamasaki; Akahito Sako; Masaya Sugiyama; Yoshihiko Aoki; Masatoshi Imamura; Kazumoto Murata; Naohiko Masaki; Takumi Kawaguchi; Takuji Torimura; Hideyuki Hyogo; Hiroshi Aikata; Kiyoaki Ito; Yoshio Sumida; Akio Kanazawa; Hirotaka Watada; Koji Okamoto; Kenjiro Honda; Kazuyoshi Kon; Tatsuya Kanto; Masashi Mizokami; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2015-09-03       Impact factor: 7.527

8.  Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients.

Authors:  Toshihide Shima; Hirofumi Uto; Kohjiro Ueki; Yutaka Kohgo; Kohichiroh Yasui; Naoto Nakamura; Tatsuaki Nakatou; Toshinari Takamura; Sumio Kawata; Kazuo Notsumata; Kyoko Sakai; Ryosuke Tateishi; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2018-07-13       Impact factor: 7.527

Review 9.  Localization and upregulation of survivin in cancer health disparities: a clinical perspective.

Authors:  Salma Khan; Heather Ferguson Bennit; Malyn May Asuncion Valenzuela; David Turay; Carlos J Diaz Osterman; Ron B Moyron; Grace E Esebanmen; Arjun Ashok; Nathan R Wall
Journal:  Biologics       Date:  2015-07-09

10.  Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.

Authors:  Hisao Imai; Kyoichi Kaira; Keita Mori; Akira Ono; Hiroaki Akamatsu; Shunichi Matsumoto; Tetsuhiko Taira; Hirotsugu Kenmotsu; Hideyuki Harada; Tateaki Naito; Haruyasu Murakami; Masahiro Endo; Takashi Nakajima; Masanobu Yamada; Toshiaki Takahashi
Journal:  BMC Cancer       Date:  2015-12-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.